Potential breakthrough in cancer treatment on the horizon?
A radical new inhibitor of Myc (a protein implicated in the formation of most human cancers) has just entered the first-in-human phase I/II clinical trials. We are looking forward to the next novel cancer treatment benefiting patients in need.
